Tauroursodeoxycholic acid

Tauroursodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Tauroursodeoxycholic acid is associated with abnormalities such as Hyperglycemia, Obesity, Wiskott-Aldrich Syndrome, neurogenic hypertension and Cholestatic liver disease. The involved functions are known as Cell Death, Apoptosis, Homeostasis, Process and mRNA Expression. Tauroursodeoxycholic acid often locates in Body tissue, Endoplasmic Reticulum, Hepatic, Blood and Protoplasm. The associated genes with Tauroursodeoxycholic acid are Homologous Gene and Mutant Proteins. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Tauroursodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tauroursodeoxycholic acid?

Tauroursodeoxycholic acid is suspected in Endothelial dysfunction, Hyperglycemia, Obesity, neurogenic hypertension, Cholestatic liver disease, Heart failure and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tauroursodeoxycholic acid

MeSH term MeSH ID Detail
Hypertension D006973 115 associated lipids
Insulin Resistance D007333 99 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with Tauroursodeoxycholic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tauroursodeoxycholic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tauroursodeoxycholic acid?

Disease model

Disease model are used in the study 'Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.' (Cortez LM et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tauroursodeoxycholic acid

Download all related citations
Per page 10 20 50 100 | Total 531
Authors Title Published Journal PubMed Link
Kok T et al. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. 2003 Biochem. J. pmid:12381268
Rodrigues CM et al. Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12721362
Häussinger D et al. Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis. 2003 Gastroenterology pmid:12730886
Chen W et al. Bile acids for viral hepatitis. 2003 Cochrane Database Syst Rev pmid:12804455
Chignard N et al. Bile salts potentiate adenylyl cyclase activity and cAMP-regulated secretion in human gallbladder epithelium. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12421748
Schoemaker MH et al. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. 2003 J. Hepatol. pmid:12873810
Beuers U et al. Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. 2003 J. Biol. Chem. pmid:12626520
Reinehr R et al. Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. 2003 Gastroenterology pmid:12949729
Sánchez Pozzi EJ et al. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis. 2003 J. Pharmacol. Exp. Ther. pmid:12663690
Lamireau T et al. Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. 2003 Life Sci. pmid:12527037
Liu Y et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. 2003 J. Clin. Invest. pmid:14623915
Heubi JE et al. Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease. 2002 J. Pediatr. pmid:12183720
Duan WM et al. Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease. 2002 Cell Transplant pmid:12075985
Xiao ZL et al. Effects of bile acids on the muscle functions of guinea pig gallbladder. 2002 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12065295
Glasova H et al. Tauroursodeoxycholic acid mobilizes alpha-PKC after uptake in human HepG2 hepatoma cells. 2002 Eur. J. Clin. Invest. pmid:12059989
Noé J et al. Functional expression of the canalicular bile salt export pump of human liver. 2002 Gastroenterology pmid:12404240
Piepoli AL et al. Tauroursodeoxycholic acid reduces damaging effects of taurodeoxycholic acid on fundus gastric mucosa. 2002 Arch. Physiol. Biochem. pmid:12221520
Pandak WM et al. Regulation of oxysterol 7alpha-hydroxylase (CYP7B1) in primary cultures of rat hepatocytes. 2002 Hepatology pmid:12029625
Azzaroli F et al. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. 2002 Hepatology pmid:12085348
Milkiewicz P et al. Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: involvement of signal transduction pathways. 2002 Gut pmid:12077103
Graf D et al. Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner. 2002 Gastroenterology pmid:11984527
Yamashita Y et al. High metabolic function of primary human and porcine hepatocytes in a polyurethane foam/spheroid culture system in plasma from patients with fulminant hepatic failure. 2002 Cell Transplant pmid:12162378
Veggi LM et al. Dapsone-induced cholestasis and impairment of bile salt output in the rat. 2002 Biochem. Pharmacol. pmid:11996898
Kim YH and Shin MJ Effects of high taurocholate load on activities of hepatic alcohol metabolizing enzymes. 2002 Exp. Mol. Med. pmid:12085987
Rodrigues CM et al. Neuroprotection by a bile acid in an acute stroke model in the rat. 2002 J. Cereb. Blood Flow Metab. pmid:11919517
Carubbi F et al. Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 2002 Biochim. Biophys. Acta pmid:11923098
Xie Q et al. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. 2002 Hepatology pmid:12198651
Venneman NG et al. Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallization in model biles. 2002 Biochim. Biophys. Acta pmid:12117566
Keene CD et al. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12149470
Alpini G et al. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. 2002 Hepatology pmid:11981754
Asamoto Y et al. Bile-salt hydrophobicity is a key factor regulating rat liver plasma-membrane communication: relation to bilayer structure, fluidity and transporter expression and function. 2001 Biochem. J. pmid:11672435
Ejiri S et al. Cellular distribution of thrombomodulin as an early marker for warm ischemic liver injury in porcine liver transplantation: protective effect of prostaglandin I2 analogue and tauroursodeoxycholic acid. 2001 Transplantation pmid:11330532
Moschetta A et al. Cholesterol crystallization in model biles: effects of bile salt and phospholipid species composition. 2001 J. Lipid Res. pmid:11483629
Kurz AK et al. Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats. 2001 Gastroenterology pmid:11487550
Ishizaki K et al. Effect of sodium tauroursodeoxycholate on phalloidin-induced cholestasis in rats. 2001 Eur. J. Pharmacol. pmid:11408049
Danchenko E et al. Effect of bile acids on the proliferative activity and apoptosis of rat hepatocytes. 2001 Exp. Toxicol. Pathol. pmid:11484843
Nathanson MH et al. Stimulation of ATP secretion in the liver by therapeutic bile acids. 2001 Biochem. J. pmid:11485545
Crocenzi FA et al. Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets. 2001 Hepatology pmid:11481618
Milkiewicz P et al. Effect of tauroursodeoxycholate and S-adenosyl-L-methionine on 17beta-estradiol glucuronide-induced cholestasis. 2001 J. Hepatol. pmid:11281545
Moschetta A et al. Hydrophilic bile salts enhance differential distribution of sphingomyelin and phosphatidylcholine between micellar and vesicular phases: potential implications for their effects in vivo. 2001 J. Hepatol. pmid:11394647
Fimognari C et al. Micronuclei induction, cell cycle delay and apoptosis as markers of cellular stress caused by ursodeoxycholic acid in human lymphocytes. 2001 Mutat. Res. pmid:11448637
Rodrigues CM et al. Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. 2001 Biochem. Biophys. Res. Commun. pmid:11181071
Colell A et al. Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione. 2001 Hepatology pmid:11679967
Keene CD et al. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. 2001 Exp. Neurol. pmid:11573988
Ishigami F et al. Bile salt tauroursodeoxycholic acid modulation of Bax translocation to mitochondria protects the liver from warm ischemia-reperfusion injury in the rat. 2001 Transplantation pmid:11740392
Beuers U et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. 2001 Hepatology pmid:11343250
Chignard N et al. Bile acid transport and regulating functions in the human biliary epithelium. 2001 Hepatology pmid:11230727
Calmus Y and Podevin P Tauroursodeoxycholic acid for the cytoprotection of liver grafts during cold storage: a new aspect of its anti-apoptotic properties? 2001 Transplantation pmid:11408962
Falasca L et al. Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. 2001 Transplantation pmid:11397961
Kurz AK et al. Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver. 2000 Biochem. J. pmid:10926845
Falasca L et al. Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study. 2000 Transplant. Proc. pmid:10700964
Benz C et al. Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. 2000 Eur. J. Clin. Invest. pmid:10691996
Piazza F et al. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid. 2000 Dig Liver Dis pmid:11515630
Rodrigues CM et al. Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition. 2000 J. Neurochem. pmid:11080188
Funaoka M et al. Tauroursodeoxycholic acid enhances phagocytosis of the cultured rat Kupffer cell. 1999 J. Gastroenterol. Hepatol. pmid:10440209
Miyake H et al. Partial characterization of mechanisms of cytoprotective action of hydrophilic bile salts against hydrophobic bile salts in rats: relation to canalicular membrane fluidity and packing density. 1999 Dig. Dis. Sci. pmid:9952244
Milkiewicz P et al. Tauroursodeoxycholate and S-adenosyl-L-methionine exert an additive ameliorating effect on taurolithocholate-induced cholestasis: a study in isolated rat hepatocyte couplets. 1999 Hepatology pmid:9918924
Hertl M et al. Tauroursodeoxycholate ameliorates reperfusion injury after pig liver transplantation. 1999 Transpl. Int. pmid:10654358
Invernizzi P et al. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. 1999 Hepatology pmid:9918905
Eckhardt U et al. Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells. 1999 Am. J. Physiol. pmid:10198348
Roda A et al. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat. 1998 Hepatology pmid:9462652
Sreejayan N and von Ritter C Effect of bile acids on lipid peroxidation: the role of iron. 1998 Free Radic. Biol. Med. pmid:9655521
Benz C et al. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. 1998 J. Hepatol. pmid:9537871
Schroeder A et al. Substrate specificity of the rat liver Na(+)-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells. 1998 Am. J. Physiol. pmid:9486191
Peterson TC et al. The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP. 1998 Immunopharmacology pmid:9754904
Klinkspoor JH et al. Bile salts stimulate mucin secretion by cultured dog gallbladder epithelial cells independent of their detergent effect. 1998 Biochem. J. pmid:9576876
Vendemiale G et al. Ethanol-induced changes of intracellular thiol compartmentation and protein redox status in the rat liver: effect of tauroursodeoxycholate. 1998 J. Hepatol. pmid:9537863
Bouscarel B et al. Changes in G protein expression account for impaired modulation of hepatic cAMP formation after BDL. 1998 Am. J. Physiol. pmid:9696716
Yamaguchi Y et al. Taurin-conjugated ursodeoxycholic acid has a reversible inhibitory effect on human keratinocyte growth. 1998 J. Dermatol. Sci. pmid:9747660
Ono T et al. Tauroursodeoxycholic acid protects cholestasis in rat reperfused livers: its roles in hepatic calcium mobilization. 1998 Dig. Dis. Sci. pmid:9790455
Benz C et al. Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes. 1998 Eur. J. Clin. Invest. pmid:9726039
Beuers U Effects of bile acids on hepatocellular signaling and secretion. 1997 Jul-Aug Yale J Biol Med pmid:9626754
Luk AS et al. Structural mechanisms of bile salt-induced growth of small unilamellar cholesterol-lecithin vesicles. 1997 Biochemistry pmid:9153403
Larghi A et al. Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study. 1997 Aliment. Pharmacol. Ther. pmid:9146783
van Nieuwerk CM et al. The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females. 1997 J. Hepatol. pmid:9148004
van de Heijning BJ et al. Membrane cholesterol content of cholesterol/phospholipid vesicles determines the susceptibility to both damage and protection by bile salts: implications for bile physiology. 1997 Eur J Gastroenterol Hepatol pmid:9187880
Setchell KD et al. Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. 1997 Gastroenterology pmid:8978363
Gilani SS et al. Use of 1H NMR spectroscopy (T2 relaxation times) to examine the effects of conjugated ursodeoxycholic acid on phospholipid fluidity of human gallbladder bile. 1997 Biochem. Soc. Trans. pmid:9056921
Crocenzi FA et al. Role of bile salts in colchicine-induced hepatotoxicity. Implications for hepatocellular integrity and function. 1997 Toxicology pmid:9230445
Rao YP et al. Activation of protein kinase C alpha and delta by bile acids: correlation with bile acid structure and diacylglycerol formation. 1997 J. Lipid Res. pmid:9458268
Takikawa H et al. Absorption of unconjugated bile acids and tauroursodeoxycholate in the rat intestine. 1997 J. Gastroenterol. Hepatol. pmid:9504891
Balandraud-Pieri N et al. Effects of tauroursodeoxycholate solutions on cyclosporin A bioavailability in rats. 1997 Drug Metab. Dispos. pmid:9280397
Loria P et al. Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans. 1997 Hepatology pmid:9185744
Arrese M et al. Adaptive regulation of hepatic bile salt transport: role of bile salt hydrophobicity and microtubule-dependent vesicular pathway. 1997 J. Hepatol. pmid:9075679
Takikawa H et al. Effect of tauro-alpha-muricholate and tauro-beta-muricholate on oestradiol-17 beta-glucuronide-induced cholestasis in rats. 1997 J. Gastroenterol. Hepatol. pmid:9076630
Schliess F et al. Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver. 1997 Gastroenterology pmid:9322526
Meier PJ et al. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. 1997 Hepatology pmid:9398014
Ishizaki K et al. Effect of sodium tauroursodeoxycholate (UR-906) on liver dysfunction in bile duct-ligated rats. 1997 Eur. J. Pharmacol. pmid:9314037
Stravitz RT et al. Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7 alpha-hydroxylase. 1996 Am. J. Physiol. pmid:8770045
Muraca M et al. Protective effect of tauroursodeoxycholate against acute gastric mucosal injury induced by hydrophobic bile salts. 1996 Dig. Dis. Sci. pmid:8654150
Sugata K et al. Differential effects between tauroursodeoxycholic and taurochenodeoxycholic acids in hepatic fibrosis: an assessment by primary cultured Ito and Kupffer cells from the rat liver. 1996 J. Gastroenterol. Hepatol. pmid:8743917
Barone M et al. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies. 1996 Hepatology pmid:8621149
Albalak A et al. Effects of submicellar bile salt concentrations on biological membrane permeability to low molecular weight non-ionic solutes. 1996 Biochemistry pmid:8672496
Nebe B et al. Induction of a physical linkage between integrins and the cytoskeleton depends on intracellular calcium in an epithelial cell line. 1996 Exp. Cell Res. pmid:8940254
Groen AK et al. Control analysis of biliary lipid secretion. 1996 J. Theor. Biol. pmid:8944177
Van Erpecum KJ et al. Effects of bile salt hydrophobicity on crystallization of cholesterol in model bile. 1996 Eur. J. Clin. Invest. pmid:8864423
Heuman DM et al. Adsorption of mixtures of bile salt taurine conjugates to lecithin-cholesterol membranes: implications for bile salt toxicity and cytoprotection. 1996 J. Lipid Res. pmid:8728319
Setchell KD et al. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. 1996 Gut pmid:8675100
Klinkspoor JH et al. Mechanism of bile salt-induced mucin secretion by cultured dog gallbladder epithelial cells. 1996 Biochem. J. pmid:8670165
Takikawa H et al. Effects of ursodeoxycholate and its conjugates on biliary glutathione excretion in rats. 1996 Dig. Dis. Sci. pmid:8888706